Oxidized LDL metabolites with high family risk for premature cardiovascular disease
- PMID: 12420906
- DOI: 10.1007/BF02723684
Oxidized LDL metabolites with high family risk for premature cardiovascular disease
Abstract
Objective: Considering the importance of primary prevention of Cardiovascular Disease (CVD) from childhood, especially in children with high family risk for premature atherosclerosis, and also the importance of oxidized LDL in the process of atherosclerosis, the main metabolites of ox-LDL i.e. Malondialdehyde (MDA) and Conjugated diene (CDE) have been measured in children of high risk families and compared with a control group.
Methods: Children and adolescents (6-18 years) of parents with premature myocardial infarction (MI < or = 55 y in men and < or = 65 y in women), were selected as the case group. The control group included neighbors of the case group matched for age and socioeconomic status. All samples have been selected by simple random sampling. Both the case and control groups were divided in two subgroups: those with a total cholesterol and/or LDL-C > or = 95th centile and those with normal lipid levels. Each subgroup consisted of 32 subjects, so 128 subjects were studied (64 in the case and 64 in the control group). MDA and CDE were measured by spectrophotometry using molar absorbivity. Data were analyzed by SPSSv10/Win software using ANOVA, Bonferroni, Scheffe-Duncan, Tukey-HSD, and the Student's t-test.
Result: The mean MDA value in the case and control groups was significantly different (1.84 +/- 0.43 vs. 1.67 +/- 0.41 micromol/L, p=0.03), but this difference was not significant regarding the mean CDE level (0.50 +/- 0.05 vs. 0.47 +/- 0.04 micromol/L, p>0.05). The mean MDA level in the case group with hyperlipidemia was significantly higher than that in the case group without hyperlipidemia (1.985 +/- 0.516 vs. 1.690 +/- 0.366, micromol/L, P=0.02) and also higher than control group with or without hyperlipidemia (1.985 +/- 0.516 vs. 1.720 +/- 0.389, 1.615 +/- 0.429 micromol/L respectively, P<0.05). The mean CDE level in the case group with hyperlipidemia was significantly higher than the case group without hyperlipidemia (0.542 +/- 0.034 vs. 0.494 +/- 0.049 micromol/L, P=0.04) and higher than the control group with or without hyperlipidemia (0.542 +/- 0.034 vs. 0.464 +/- 0.051, 0.484 +/- 0.048 micromol/L respectively, p<0.05). In case boys with hyperlipidemia, the mean MDA (2.03 +/- 0.2 micromol/L) and the mean of CDE (0.56 +/- 0.04 micromol/L) was significantly higher than other subgroups (P<0.05).
Conclusion: Considering the increased susceptibility of LDL to oxidation in children with high family risk for premature CVD, special attention should be paid to consumption of foods and seasoning containing antioxidants from childhood especially in high risk families.
Similar articles
-
Lipid profile, low-density lipoprotein oxidation and ceruloplasmin in the progeny of families with a positive history of cardiovascular diseases and/or hyperlipidemia.Angiology. 2009 Aug-Sep;60(4):455-61. doi: 10.1177/0003319709338174. Epub 2009 Jul 31. Angiology. 2009. PMID: 19648144
-
New atherosclerosis risk factors in obese, hypertensive and diabetic children and adolescents.Atherosclerosis. 2003 Apr;167(2):275-86. doi: 10.1016/s0021-9150(03)00003-0. Atherosclerosis. 2003. PMID: 12818410
-
HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.Neuro Endocrinol Lett. 2011;32(4):502-9. Neuro Endocrinol Lett. 2011. PMID: 21876506 Clinical Trial.
-
Lipid profile in children aged 5 to 15 years with parental history of ischemic heart disease, hypertension and diabetes mellitus.Indian Pediatr. 2002 Feb;39(2):168-72. Indian Pediatr. 2002. PMID: 11867847 No abstract available.
-
[Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].Pol Arch Med Wewn. 2005 Feb;113(2):119-29. Pol Arch Med Wewn. 2005. PMID: 16209232 Polish.
Cited by
-
Factor analysis of markers of inflammation and oxidation and echocardiographic findings in children with a positive family history of premature coronary heart disease.Pediatr Cardiol. 2009 May;30(4):477-81. doi: 10.1007/s00246-009-9412-7. Epub 2009 Mar 26. Pediatr Cardiol. 2009. PMID: 19322601
-
Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.Open Cardiovasc Med J. 2010;4:24-9. doi: 10.2174/1874192401004020024. Epub 2010 Feb 23. Open Cardiovasc Med J. 2010. PMID: 21804638 Free PMC article.
-
Is family history of premature cardiovascular diseases appropriate for detection of dyslipidemic children in population-based preventive medicine programs? CASPIAN study.Pediatr Cardiol. 2006 Nov-Dec;27(6):729-36. doi: 10.1007/s00246-006-1391-3. Epub 2006 Nov 16. Pediatr Cardiol. 2006. PMID: 17111289
-
Dan-Lou Prescription Inhibits Foam Cell Formation Induced by ox-LDL via the TLR4/NF-κB and PPARγ Signaling Pathways.Front Physiol. 2018 May 29;9:590. doi: 10.3389/fphys.2018.00590. eCollection 2018. Front Physiol. 2018. PMID: 29896109 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous